3070 Release 24 HR Methylphenidate Hydrochloride 60 MG Extended Release Oral Capsule
1 INDICATIONS AND USAGE Methylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age. Methylphenidate hydrochloride extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age. (1)
Amneal Pharmaceuticals of New York LLC
Related Pills
3070 Release 24 HR Methylphenidate Hydrochloride 60 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
3070 Release 24 HR Methylphenidate Hydrochloride 50 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
3070 Release 24 HR Methylphenidate Hydrochloride 40 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
3070 Release 24 HR Methylphenidate Hydrochloride 30 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
3070 Release 24 HR Methylphenidate Hydrochloride 20 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
3070 Release 24 HR Methylphenidate Hydrochloride 10 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules are available in six strengths:
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, 10 mg are green cap and white body, opaque capsules, imprinted with âCPâ over â401â on the cap and â10 mgâ on the body. They are available as: Bottles of 100: NDC 0115-1736-01
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, 20 mg are blue cap and white body, opaque capsules, imprinted with âCPâ over â402â on the cap and â20 mgâ on the body. They are available as: Bottles of 100: NDC 0115-1737-01
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, 30 mg are brown cap and white body, opaque capsules, imprinted with âCPâ over â403â on the cap and â30 mgâ on the body. They are available as: Bottles of 100: NDC 0115-1738-01
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, 40 mg are yellow cap and white body, opaque capsules, imprinted with âCPâ over â404â on the cap and â40 mgâ on the body. They are available as: Bottles of 100: NDC 0115-1739-01
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, 50 mg are navy blue cap and white body, opaque capsules, imprinted with âCPâ over â405â on the cap and â50 mgâ on the body. They are available as: Bottles of 100: NDC 0115-1740-01
METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, 60 mg are white opaque capsule imprinted with âCPâ over â406â on the cap and â60 mgâ on the body. They are available as: Bottles of 100: NDC 0115-1741-01 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep out of the reach of children.
More pills like CAPSULE CP 406 60mg